HIV 1 News and Research

RSS

LSUHSC dental school wins $1.8M grant to educate students about caring for HIV/AIDS patients

The LSU Health Sciences Center New Orleans School of Dentistry has been awarded a $1.8 million grant over five years by the Health Resources and Services Administration to support a "Community-Based Dental Partnership." Under the direction of Robert Barsley, DDS, JD, the program educates dental and dental hygiene students about caring for patients with HIV/AIDS, provides dental services to this patient population, and monitors quality of care.

2 Aug 2013

Using the immune system to control cancer: an interview with Dr. Jedd Wolchok, MD, PhD, Ludwig Center at MSKCC

Cancer immunotherapy aims to recruit a patient’s immune system to recognize cancer as foreign and dangerous and to remove it from the body, as it would an infection.

1 Aug 2013

Experts say action needed urgently to ensure India's new policy does not backfire

In an editorial published online today in BMJ, Johns Hopkins bioethicist Jeremy Sugarman and other experts warn that action is urgently needed to deal with possible unintended consequences of India's new policy protecting research participants.

1 Aug 2013

Experts address ethical issues raised by FDA's approval of Truvada for HIV prevention

The Food and Drug Administration's approval last year of the drug Truvada for prevention of HIV infection was a milestone in the fight against HIV/AIDS, but experts are cautioning that it is only the beginning of new ethical concerns for health care professionals, policy makers, researchers and those taking Truvada to prevent HIV infection.

1 Aug 2013

Researchers secure $16 million NIH grant to investigate impact of HIV/AIDS on women

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center today announced they received a $16 million grant from the National Institutes of Health to investigate the impact of HIV and AIDS on women.

31 Jul 2013

USF professor receives grant to study ways to reduce HIV/AIDS risk in college-aged black women

The National Institute of Nursing Research (NINR) awarded $267,732 to the University of South Florida College of Nursing to study ways to reduce HIV/AIDS risk in college-aged black women, who are disproportionately affected by the disease. Rasheeta D. Chandler, PhD, ARNP, FNP-BC, assistant professor of nursing at USF, will lead the study.

31 Jul 2013

WHO aims to increase global rate of breastfeeding for six months to 50% by 2025

Only 37 countries, or 19% of those reporting, have passed laws reflecting all the recommendations of the International Code of Marketing of Breast-milk Substitutes, according to a new World Health Organization (WHO) report published during World Breastfeeding Week. The week is celebrated in more than 170 countries from 1 to 7 August.

30 Jul 2013

METH use can make person more susceptible to fungal lung infection

Methamphetamine use can make a person more susceptible to the lung infection cryptococcosis, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.

30 Jul 2013

Professor receives Celebration of African Australians Inc Award for exceptional research works

Professor Vanessa Hayes received a Celebration of African Australians Inc Award at Parliament House on Saturday.

30 Jul 2013

Social networks of homeless youth can be highly influential in reducing risky behaviors

Homeless young women may be at greater risk for sexually transmitted infections (STIs) than homeless young men because of the structure of their social groups and friendships, according to new research from UC San Francisco. The findings underscore how the social networks of homeless youth can be highly influential, affecting their participation in risky and protective behaviors.

30 Jul 2013

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Genotype 1 is, worldwide, the most prevalent genotype of the hepatitis C virus. It accounts for around seventy percent of all hepatitis C infections.

30 Jul 2013

Hope for treatment of childhood infections may come straight from the gut: Therapeutic poop

Call it therapeutic poop, if you will, but the best hope yet for an effective treatment of childhood infections with the drug-resistant bacterium C. difficile may come straight from the gut, according to recent research.

30 Jul 2013

Genistein derived from soybeans shows promise in inhibiting HIV infection

A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers.

30 Jul 2013

Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago

The USPSTF agreed with the CDC that since most patients (75%) who are currently infected with hepatitis C were born between 1945 - 1965, and since risk-based screening has not been successful in identifying these individuals, that a one time age-based hepatitis C blood test was necessary.

29 Jul 2013

World Hepatitis Alliance calls for urgent action to address viral hepatitis

On World Hepatitis Day, the World Hepatitis Alliance has called for urgent attention to be given to recent figures showing that although viral hepatitis kills as many as HIV/AIDS, the great majority of countries have no programmes in place to tackle it.

29 Jul 2013

Viewpoints: Doctors' sway over Medicare pay; hospital rankings not all they seem; legal immigrants' health needs overlooked

Reporters Peter Whoriskey and Dan Keating have opened Post readers' eyes to the fact that Medicare pays for physician services -; a $69.6 billion item in 2012 -; according to an arcane and little-known price list, over which doctors themselves exercise considerable and less-than-totally-transparent influence (7/24).

26 Jul 2013

Miriam researcher calls for new strategies to better manage, improve treatment for HCV infection

A Miriam Hospital researcher has joined forces with international colleagues to call for new strategies to better manage and improve assessment and treatment for hepatitis C (HCV) infection in individuals who inject drugs.

26 Jul 2013

FDA allows marketing of Xpert MTB/RIF Assay for treatment of TB

The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.

26 Jul 2013

Combination of 6 comprehensive measures to prevent spread of hepatitis C

UC San Francisco researchers are recommending a combination of six comprehensive measures to prevent the spread of hepatitis C, in an effort to address the more than 31,000 young people they estimate may be newly infected with the virus each year in the United States due to injection-drug use.

25 Jul 2013

Researcher identify genetic mutation in Africans with HIV that puts them at higher risk for tuberculosis

A researcher from the Perelman School of Medicine at the University of Pennsylvania and colleagues have identified the genetic mutation in Africans with HIV that puts them at a much higher risk for tuberculosis (TB) infections.

25 Jul 2013

HIV 1 News and Research

LSUHSC dental school wins $1.8M grant to educate students about caring for HIV/AIDS patients

Using the immune system to control cancer: an interview with Dr. Jedd Wolchok, MD, PhD, Ludwig Center at MSKCC

Experts say action needed urgently to ensure India's new policy does not backfire

Experts address ethical issues raised by FDA's approval of Truvada for HIV prevention

Researchers secure $16 million NIH grant to investigate impact of HIV/AIDS on women

USF professor receives grant to study ways to reduce HIV/AIDS risk in college-aged black women

WHO aims to increase global rate of breastfeeding for six months to 50% by 2025

METH use can make person more susceptible to fungal lung infection

Professor receives Celebration of African Australians Inc Award for exceptional research works

Social networks of homeless youth can be highly influential in reducing risky behaviors

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Hope for treatment of childhood infections may come straight from the gut: Therapeutic poop

Genistein derived from soybeans shows promise in inhibiting HIV infection

Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago

World Hepatitis Alliance calls for urgent action to address viral hepatitis

Viewpoints: Doctors' sway over Medicare pay; hospital rankings not all they seem; legal immigrants' health needs overlooked

Miriam researcher calls for new strategies to better manage, improve treatment for HCV infection

FDA allows marketing of Xpert MTB/RIF Assay for treatment of TB

Combination of 6 comprehensive measures to prevent spread of hepatitis C

Researcher identify genetic mutation in Africans with HIV that puts them at higher risk for tuberculosis

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News